opioid withdrawal

opioid withdrawal

Substance abuse An acute state caused by withdrawal of opioid narcotics from a person addicted to narcotics Clinical Sweating, shaking, headache, craving, vomiting, abdominal cramping, diarrhea, insomnia, confusion, agitation, other behavioral changes. See Neonatal withdrawal syndrome.
References in periodicals archive ?
Whereas increasing dosages of methadone increase the risk of respiratory depression, increasing doses of buprenorphine likely increases the risk of opioid withdrawal.
Chu described opioid withdrawal as a "bad flu," characterized by agitation, insomnia, diarrhea, nausea and vomiting.
Clinical Opioid Withdrawal Scale) before substitution opioids are administered, to prevent accidental overdose (full agonists) or precipitate withdrawal (partial agonists).
Cocores' letter are not only not Food and Drug Administration-approved for the management of opioid withdrawal, but are not even commonly reported in addiction medicine journals or meetings.
VIVITROL is contraindicated in patients with acute hepatitis or liver failure, patients receiving opioid analgesics, patients with current physiologic opioid dependence, patients in acute opioid withdrawal, any individual who has failed the naloxone challenge test or has a positive urine screen for opioids, and in patients who have previously exhibited hypersensitivity to naltrexone, polylactide-co-glycolide (PLG), carboxymethylcellulose or any other components of the diluent.
Neonatal opioid withdrawal syndrome, unlike opioid withdrawal syndrome in adults, may be life threatening if not recognized and treated and requires management according to protocols developed by neonatology experts.
ER WARNING: ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; and INTERACTION WITH ALCOHOL
Importantly, there was no sign of central opioid withdrawal or loss of analgesic effect in the 2-week study.
There were no differences between groups in subjective or objective measures of opioid withdrawal or patient reported pain.
21, 2015 /PRNewswire-USNewswire/ -- In conjunction with President Obama's announcement of local, state and federal efforts to address the growing problem of opioid misuse and abuse, local leaders today announced a new cooperative purchasing agreement to expand public agencies' access to potentially lifesaving opioid withdrawal medications.
The agents he suggested are not only not Food and Drug Administration-approved for the management of opioid withdrawal, but are not even commonly reported in addiction medicine journals or meetings.
But triptan withdrawal also can mimic opioid withdrawal with associated nausea, diarrhea, and abdominal pain.